Xoma reported $154.22M in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Agenus AGEN:US $ 456.17M 14.87M
Agios Pharmaceuticals AGIO:US $ 1252.47M 83.39M
Biomarin Pharmaceutical BMRN:US $ 6145.84M 83.13M
Bluebird Bio BLUE:US $ 573.59M 82.52M
Celldex Therapeutics CLDX:US $ 402.96M 21.08M
Chimerix CMRX:US $ 53.56M 11.95M
Curis CRIS:US $ 128.83M 11.9M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Emergent Biosolutions EBS:US $ 2735.4M 45M
Epizyme EPZM:US $ 264.16M 48.03M
Intercept Pharmaceuticals ICPT:US $ 498.6M 4.76M
Life Technologies LIFE:US $ 104.78M 10.76M
Macrogenics MGNX:US $ 218.04M 53.4M
Novartis NVS:US $ 122910M 2308M
Novartis NOVN:VX SF 122910M 2308M
Prothena PRTA:US $ 549.59M 31.82M
Regeneron Pharmaceuticals REGN:US $ 27205.8M 857.1M
Teva Pharmaceutical Industries TEVA:US $ 45932M 1127M
Xoma XOMA:US $ 154.22M 4.94M
YTE INCY:US $ 5319.04M 264.81M